V
Vectorious Medical Technologies
Developed an in-heart microcomputer that monitors the heart’s left atrium pressure, thereby enabling optimal treatment of heart disease patient
About Vectorious Medical Technologies
Vectorious Medical Technologies is a pioneering startup in the medical technology sector, specializing in the early detection and management of heart failure. The company has developed the V-LAP, the world's first in-heart microcomputer, which provides real-time monitoring of left atrial pressure (LAP). This innovative device allows physicians to detect heart failure at its earliest stages, even before symptoms appear, enabling more effective and timely treatment.
Read full description
Vectorious primarily serves cardiologists and healthcare providers who treat patients with heart failure. The company operates in the global healthcare market, focusing on regions with high incidences of heart disease. By providing continuous, real-time data on heart pressure, the V-LAP device helps doctors make informed decisions about patient care, potentially reducing hospital readmissions and lowering mortality rates.
The business model of Vectorious revolves around the sale and distribution of the V-LAP device to hospitals and clinics. Additionally, the company may generate revenue through ongoing service agreements, including data analytics and support services, which help healthcare providers interpret the data collected by the device. The use of advanced AI algorithms enhances the value of the data, providing actionable insights that can improve patient outcomes.
Vectorious has received funding from the European Union's Horizon 2020 research and innovation program, which underscores the credibility and potential impact of its technology. The company aims to transform the treatment of heart failure, improving the quality of life for millions of patients worldwide.
At a glance
- Status
- Acquired
- Founded
- 2011
- Headquarters
- Tel Aviv-Yafo, Israel
- Employees
- 115
- Open positions
- 3
- Dealroom signal
- 84.8/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Risk Management, Biotechnology, medical implants, Cardiology and cardiovascular
- Technology
- Artificial Intelligence, Deep Tech, Computer Vision, Connected Device, Recognition Technology
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Sep 2025 | $239M | $497M | Edwards Lifesciences | ↗ |
| ACQUISITION✓Exit | Jan 2023 | $258M | $497M | Edwards Lifesciences | ↗ |
Growth signals
Latest recorded traffic for Vectorious Medical Technologies is 1.2K monthly website visits, up 605.9% over the last three months. Vectorious Medical Technologies's team grew 5.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed2 investors entered at this stage
European Innovation Council
The Israel Innovation Authority
Series A4 investors entered at this stage
Yehuda Zisapel
Zohar Gilon
Broadview Ventures
GEOC - China-Israel fund
Other known investors3 additional known investors
Edwards Lifesciences
Amit Gilon
RAD BioMed
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Vectorious Medical Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Vectorious Medical Technologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.